Culture Biosciences is a synthetic biology company offering a bioreactor facility for fermentation on demand services that is headquartered in San Francisco, California and was founded in 2016 by Will Patrick. The company allows other biotechnology and synthetic biology companies to test their new strains and process parameters using Culture Biosciences facilities. Companies send their organisms into Culture Biosciences for experimentation, and they can monitor their experiments remotely, view their data, and receive samples after their experiment is complete. Notable companies that have used Culture Biosciences are: Modern Meadow, Synlogic, Povot Bio, Geltor, and Asimov.
On February 12, 2019 Culture Biosciences completed a venture capital funding round with $5.5 million in funding from Section 32 (lead investor) and Refactor Capital. The company will be using their funding to develop additional bioreactor facilities and to expand its digital biomanufacturing platform. The CEO of Culture Biosciences, Will Patrick, made the following public statement after the companies successful venture capital round:
Our goal is to make fermentation a digital experience, empowering scientists to run experiments from their computers in the same way a software engineer tests and compiles code. We're proud to have the support of such committed investors as we pursue our vision of supporting companies as they build breakthrough products.